Repository logo
  • English
  • 中文
Log In
Have you forgotten your password?
  1. Home
  2. College of Medicine / 醫學院
  3. Medical Education and Bioethics / 醫學教育暨生醫倫理研究所
  4. Circulating TNFSF14 (Tumor Necrosis Factor Superfamily 14) Predicts Clinical Outcome in Patients with Stable Coronary Artery Disease
 
  • Details

Circulating TNFSF14 (Tumor Necrosis Factor Superfamily 14) Predicts Clinical Outcome in Patients with Stable Coronary Artery Disease

Journal
Arteriosclerosis, Thrombosis, and Vascular Biology
Journal Volume
39
Journal Issue
6
Pages
1240-1252
Date Issued
2019
Author(s)
Hsu C.-Y.
Tseng W.-K.
YEN-WEN WU  
Lin T.-H.
Yeh H.-I.
Chang K.-C.
Wang J.-H.
Chou R.-H.
Huang C.-Y.
Huang P.-H.
Leu H.-B.
Yin W.-H.
CHAU-CHUNG WU  
Lin S.-J.
Chen J.-W.
DOI
10.1161/ATVBAHA.118.312166
URI
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85066509638&doi=10.1161%2fATVBAHA.118.312166&partnerID=40&md5=b4464ec448fe74ac0d05b17b6131008c
https://scholars.lib.ntu.edu.tw/handle/123456789/469744
Abstract
Objective-Basic research indicates that TNFSF14 (tumor necrosis factor superfamily 14) may be involved in the pathogenesis of atherosclerosis. Given the requirements of new biomarkers for risk classification in coronary artery disease (CAD), we conducted a longitudinal analysis to investigate if TNFSF14 levels are associated with the risk of cardiovascular events among patients with stable CAD. Approach and Results-In total, 894 patients with CAD were enrolled in a multicenter prospective study. The primary outcome was the occurrence of cardiovascular death, nonfatal myocardial infarction, and stroke. The secondary outcome was the occurrence of all-cause death, nonfatal myocardial infarction, stroke, revascularization, and hospitalization because of angina or heart failure. During the mean follow-up period of 22±9 months, 32 patients reached the primary outcome and 166 patients reached the secondary outcome. Kaplan-Meier analysis showed that the event-free survival was significantly different in the first and fourth quartile groups in subjects categorized by TNFSF14 levels. In multivariate Cox proportional hazard regression analysis, TNFSF14 was independently associated with the risk of cardiovascular events after adjustment for various relevant factors (adjusted hazard ratio, 1.14; 95% CI, 1.04-1.25). In the validation cohort of 126 multivessel patients with CAD, TNFSF14 was confirmed to provide good prognostic predictive value for composite cardiovascular events (adjusted hazard ratio, 1.11; 95% CI, 1.04-1.19). Conclusions-This is the first study to demonstrate that increased TNFSF14 levels were independently associated with the occurrence of cardiovascular events in patients with stable CAD. Future studies are worthy to validate if TNFSF14 could be a novel prognostic biomarker for CAD outcomes over different populations. ? 2019 ? 2019 American Heart Association, Inc. All rights reserved.
SDGs

[SDGs]SDG3

Other Subjects
adiponectin; amino terminal pro brain natriuretic peptide; biological marker; cytokine; gelatinase B; interleukin 6; tumor necrosis factor; tumor necrosis factor superfamily 14; unclassified drug; biological marker; herpesvirus entry mediator ligand; TNFSF14 protein, human; adult; all cause mortality; Article; cardiovascular mortality; cardiovascular risk; cerebrovascular accident; clinical outcome; cohort analysis; coronary artery disease; electrocardiogram; event free survival; female; follow up; heart infarction; heart muscle revascularization; hospitalization; human; Kaplan Meier method; laboratory test; major clinical study; male; middle aged; multicenter study; observational study; outcome assessment; predictive value; priority journal; prospective study; protein blood level; aged; blood; cause of death; clinical trial; coronary artery disease; disease exacerbation; epidemiology; incidence; longitudinal study; mortality; risk assessment; risk factor; Taiwan; time factor; upregulation; very elderly; Aged; Aged, 80 and over; Biomarkers; Cause of Death; Coronary Artery Disease; Disease Progression; Female; Hospitalization; Humans; Incidence; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Progression-Free Survival; Prospective Studies; Risk Assessment; Risk Factors; Stroke; Taiwan; Time Factors; Tumor Necrosis Factor Ligand Superfamily Member 14; Up-Regulation
Publisher
Lippincott Williams and Wilkins
Type
journal article

臺大位居世界頂尖大學之列,為永久珍藏及向國際展現本校豐碩的研究成果及學術能量,圖書館整合機構典藏(NTUR)與學術庫(AH)不同功能平台,成為臺大學術典藏NTU scholars。期能整合研究能量、促進交流合作、保存學術產出、推廣研究成果。

To permanently archive and promote researcher profiles and scholarly works, Library integrates the services of “NTU Repository” with “Academic Hub” to form NTU Scholars.

總館學科館員 (Main Library)
醫學圖書館學科館員 (Medical Library)
社會科學院辜振甫紀念圖書館學科館員 (Social Sciences Library)

開放取用是從使用者角度提升資訊取用性的社會運動,應用在學術研究上是透過將研究著作公開供使用者自由取閱,以促進學術傳播及因應期刊訂購費用逐年攀升。同時可加速研究發展、提升研究影響力,NTU Scholars即為本校的開放取用典藏(OA Archive)平台。(點選深入了解OA)

  • 請確認所上傳的全文是原創的內容,若該文件包含部分內容的版權非匯入者所有,或由第三方贊助與合作完成,請確認該版權所有者及第三方同意提供此授權。
    Please represent that the submission is your original work, and that you have the right to grant the rights to upload.
  • 若欲上傳已出版的全文電子檔,可使用Open policy finder網站查詢,以確認出版單位之版權政策。
    Please use Open policy finder to find a summary of permissions that are normally given as part of each publisher's copyright transfer agreement.
  • 網站簡介 (Quickstart Guide)
  • 使用手冊 (Instruction Manual)
  • 線上預約服務 (Booking Service)
  • 方案一:臺灣大學計算機中心帳號登入
    (With C&INC Email Account)
  • 方案二:ORCID帳號登入 (With ORCID)
  • 方案一:定期更新ORCID者,以ID匯入 (Search for identifier (ORCID))
  • 方案二:自行建檔 (Default mode Submission)
  • 方案三:學科館員協助匯入 (Email worklist to subject librarians)

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science